Literature DB >> 12414081

Cross-national cognitive assessment in schizophrenia clinical trials: a feasibility study.

Philip D Harvey1, Lidia Artiola i Fortuny, Estelle Vester-Blockland, Goedele De Smedt.   

Abstract

Clinical trials for the treatment of schizophrenia now often include cognitive assessments in addition to clinical ratings of symptoms. Recently, these trials have included cross-national assessments. It is not clear if translated psychological tests produce consistent results across different languages. This paper presents the results of a study of the comparability of the results of cognitive assessments in different English-speaking countries and a number of countries where tests were translated into other languages. Performance on tests of executive functioning, verbal and visuo-spatial learning and memory, language skills, psychomotor speed, and vigilance was compared across the first episode patients with schizophrenia (n = 301) assessed in six different languages (English, French, Finnish, German, Hebrew, and Afrikaans), including two different countries where patients were assessed in English and other languages: Canada (French) and South Africa (Afrikaans). The variance in performance across the sites tested in English was as large as the variance between English and non-English speakers when all tests were considered. Performance differences across English and other languages were found only for executive functions, vigilance, and psychomotor speed, with executive functioning differences nonsignificant when education was considered. No differences were found between English and non-English speakers in Canada. These results suggest that the translation of tests of memory and verbal skills can lead to consistent results across translated versions of the tests. Differences between countries were greater than differences between languages, suggesting the need to consider representativeness of patient samples in terms of local educational attainment. In general, these data support the validity of cross-national neuropsychological assessments. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12414081     DOI: 10.1016/s0920-9964(02)00153-6

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Trajectories and antecedents of treatment response over time in early-episode psychosis.

Authors:  Stephen Z Levine; J Rabinowitz
Journal:  Schizophr Bull       Date:  2008-10-09       Impact factor: 9.306

2.  International assessment of functional skills in people with schizophrenia.

Authors:  Philip D Harvey; Dawn I Velligan
Journal:  Innov Clin Neurosci       Date:  2011-01

3.  Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia.

Authors:  Samir Sabbag; Davide Prestia; Belinda Robertson; Pedro Ruiz; Dante Durand; Martin Strassnig; Philip D Harvey
Journal:  Psychiatry Res       Date:  2015-07-02       Impact factor: 3.222

Review 4.  A systematic review of research on neuropsychological measures in psychotic disorders from low and middle-income countries: The question of clinical utility.

Authors:  Emmanuel K Mwesiga; Dickens Akena; Nastassja Koen; Richard Senono; Ekwaro A Obuku; Joy Louise Gumikiriza; Reuben N Robbins; Noeline Nakasujja; Dan J Stein
Journal:  Schizophr Res Cogn       Date:  2020-08-24

Review 5.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

6.  Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.

Authors:  Philip D Harvey; Lars Helldin; Christopher R Bowie; Robert K Heaton; Anna-Karin Olsson; Fredrik Hjärthag; Torsten Norlander; Thomas L Patterson
Journal:  Am J Psychiatry       Date:  2009-06-01       Impact factor: 18.112

7.  Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.

Authors:  J Cobb Scott; Tyler M Moore; Dan J Stein; Adele Pretorius; Zukiswa Zingela; Mohammed Nagdee; Linda Ngqengelele; Megan Campbell; Goodman Sibeko; Mary Claire King; Jon M McClellan; Allison M Port; Chad Jackson; Kosha Ruparel; Ezra S Susser; Ruben C Gur
Journal:  Neuropsychology       Date:  2021-07-05       Impact factor: 3.424

8.  Neurocognitive Impairment in Severe Mental Illness. Comparative study with Spanish Speaking Patients.

Authors:  Gabriel G De la Torre; Sandra Doval; David López-Sanz; Manuel García-Sedeño; Miguel A Ramallo; Macarena Bernal; Sara González-Torre
Journal:  Brain Sci       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.